Idiopathic pulmonary fibrosis overview: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Idiopathic pulmonary fibrosis }} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Pulmonology Category:Disease")
 
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
''' [[Idiopathic]] Pulmonary Fibrosis (IPF)''', is a chronic progressive interstitial lung disease of unknown etiology. It is one of the two classic interstitial lung diseases, the other being sarcoidosis.<ref name="WMMT">{{cite book |title=The Washington Manual of Medical Therapeutics |last=Cooper |first=Daniel H. |coauthors=Andrew J. Krainik, Sam J. Lubner, Hilary E. L. Reno (eds.)|edition=32nd edition |publisher=Lippincott Williams & Wilkins |pages=276 |isbn=978-0781781251}}</ref>
More specifically, '''IPF''' is defined as a distinctive type of ''chronic fibrosing interstitial pneumonia'' of unknown cause associated with a histological pattern of [[usual interstitial pneumonia]] (UIP).<ref name="ATS">{{cite journal |url=http://ajrccm.atsjournals.org/cgi/content/full/161/2/646 |title=Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment |journal=American Journal of Respiratory and Critical Care Medicine |volume=161 |number=2 |month=February |year=2000 |pages=646-664}}</ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 19:21, 25 September 2012

Idiopathic pulmonary fibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Idiopathic pulmonary fibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Idiopathic pulmonary fibrosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Idiopathic pulmonary fibrosis overview

CDC on Idiopathic pulmonary fibrosis overview

Idiopathic pulmonary fibrosis overview in the news

Blogs on Idiopathic pulmonary fibrosis overview

Directions to Hospitals Treating Idiopathic pulmonary fibrosis

Risk calculators and risk factors for Idiopathic pulmonary fibrosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Idiopathic Pulmonary Fibrosis (IPF), is a chronic progressive interstitial lung disease of unknown etiology. It is one of the two classic interstitial lung diseases, the other being sarcoidosis.[1]

More specifically, IPF is defined as a distinctive type of chronic fibrosing interstitial pneumonia of unknown cause associated with a histological pattern of usual interstitial pneumonia (UIP).[2]

References

  1. Cooper, Daniel H. The Washington Manual of Medical Therapeutics (32nd edition ed.). Lippincott Williams & Wilkins. p. 276. ISBN 978-0781781251. Unknown parameter |coauthors= ignored (help)
  2. "Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment". American Journal of Respiratory and Critical Care Medicine. 161 (2): 646–664. 2000. Unknown parameter |month= ignored (help)

Template:WH Template:WS